Beliefs, experiences and concerns of using artificial intelligence in healthcare: A qualitative synthesis.

Autor: Fazakarley CA; Ultromics Ltd, Oxford, UK., Breen M; Breen Clinical Research, London, UK., Thompson B; Ultromics Ltd, Oxford, UK., Leeson P; RDM Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Williamson V; King's Centre for Military Health Research, King's College London, London, UK.

Publikováno v: Digital health [Digit Health] 2024 Feb 11; Vol. 10, pp. 20552076241230075. Date of Electronic Publication: 2024 Feb 11 (Print Publication: 2024).

PROTEUS Study: A Prospective Randomized Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography.

Autor: Woodward G; Ultromics Ltd., Oxford, UK., Bajre M; Oxford Academic Health Science Network, Magdalen Centre-Whitehead Building, Oxford, UK., Bhattacharyya S; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London, UK., Breen M; Ultromics Ltd., Oxford, UK., Chiocchia V; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Dawes H; Oxford Clinical Allied Technology and Trial Services Unit, Oxford Brookes University, Oxford, UK., Dehbi HM; UCL Comprehensive Clinical Trials Unit, University College London, London, UK., Descamps T; Ultromics Ltd., Oxford, UK., Frangou E; MRC Clinical Trials Unit at UCL, London, UK., Fazakarley CA; Ultromics Ltd., Oxford, UK., Harris V; Department of Primary Health Care Sciences, University of Oxford, Oxford, UK., Hawkes W; Ultromics Ltd., Oxford, UK., Hewer O; Ultromics Ltd., Oxford, UK., Johnson CL; Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Krasner S; Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Laidlaw L; British Society of Echocardiography. (BSE) Wavelength PPI group member, NIHR and BMJ lay reviewer., Lau J; Ultromics Ltd., Oxford, UK., Marwick T; Baker Heart and Diabetes Institute, Melbourne Victoria, Australia., Petersen SE; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London, UK; William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University London, Charterhouse Square, London, UK., Piotrowska H; Ultromics Ltd., Oxford, UK., Ridgeway G; Oxford Brain Diagnostics Ltd, Oxford Centre for Innovation, Oxford, UK., Ripley DP; School of Medicine, Faculty of Health Sciences and Wellbeing, University of Sunderland, London, UK., Sanderson E; Ultromics Ltd., Oxford, UK., Savage N; Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Sarwar R; Ultromics Ltd., Oxford, UK., Tetlow L; Ultromics Ltd., Oxford, UK., Thompson B; Ultromics Ltd., Oxford, UK., Thulborn S; Ultromics Ltd., Oxford, UK., Williamson V; Ultromics Ltd., Oxford, UK., Woodward W; Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Upton R; Ultromics Ltd., Oxford, UK., Leeson P; Cardiovascular Clinical Research Facility, RDM Division of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. Electronic address: paul.leeson@cardiov.ox.ac.uk.

Publikováno v: American heart journal [Am Heart J] 2023 Sep; Vol. 263, pp. 123-132. Date of Electronic Publication: 2023 May 14.